You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

SORBITRATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sorbitrate patents expire, and what generic alternatives are available?

Sorbitrate is a drug marketed by Astrazeneca and is included in six NDAs.

The generic ingredient in SORBITRATE is isosorbide dinitrate. There are thirty-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sorbitrate

A generic version of SORBITRATE was approved as isosorbide dinitrate by ENDO OPERATIONS on March 12th, 1987.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SORBITRATE?
  • What are the global sales for SORBITRATE?
  • What is Average Wholesale Price for SORBITRATE?
Summary for SORBITRATE
Drug patent expirations by year for SORBITRATE
Recent Clinical Trials for SORBITRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Council of Science and Technology, MexicoPhase 4
National Institute of PerinatologyPhase 4

See all SORBITRATE clinical trials

US Patents and Regulatory Information for SORBITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca SORBITRATE isosorbide dinitrate TABLET, CHEWABLE;ORAL 016776-002 Apr 1, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astrazeneca SORBITRATE isosorbide dinitrate TABLET;ORAL 088125-001 Aug 21, 1990 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astrazeneca SORBITRATE isosorbide dinitrate TABLET;ORAL 016192-002 Apr 1, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astrazeneca SORBITRATE isosorbide dinitrate TABLET;SUBLINGUAL 016191-002 Apr 1, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astrazeneca SORBITRATE isosorbide dinitrate TABLET, CHEWABLE;ORAL 016776-003 Apr 1, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astrazeneca SORBITRATE isosorbide dinitrate TABLET;ORAL 016192-001 Apr 1, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.